Xponance’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Buy |
3,372
+58
| +2% | +$4K | ﹤0.01% | 1258 |
|
|
2025
Q1 | $230K | Buy |
3,314
+158
| +5% | +$11K | ﹤0.01% | 1217 |
|
|
2024
Q4 | $271K | Buy |
3,156
+146
| +5% | +$12.6K | ﹤0.01% | 1164 |
|
|
2024
Q3 | $358K | Buy |
3,010
+345
| +13% | +$41.1K | ﹤0.01% | 1036 |
|
|
2024
Q2 | $380K | Buy |
2,665
+576
| +28% | +$82.2K | ﹤0.01% | 986 |
|
|
2024
Q1 | $268K | Buy |
2,089
+32
| +2% | +$4.11K | ﹤0.01% | 1094 |
|
|
2023
Q4 | $213K | Sell |
2,057
-671
| -25% | -$69.4K | ﹤0.01% | 1142 |
|
|
2023
Q3 | $248K | Buy |
+2,728
| New | +$248K | ﹤0.01% | 1078 |
|